awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35015866-2931A607-7920-4CA1-BAE1-892C51FA151C
Q35015866-2931A607-7920-4CA1-BAE1-892C51FA151C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35015866-2931A607-7920-4CA1-BAE1-892C51FA151C
Treatment targeted to cell surface epitopes.
P2860
Q35015866-2931A607-7920-4CA1-BAE1-892C51FA151C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35015866-2931A607-7920-4CA1-BAE1-892C51FA151C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7544ae023e9107bc89d3e5a4627fbbe131fc9fcd
P2860
Anti-interleukin-2 receptor antibodies: basiliximab and daclizumab.